226.27
price down icon0.54%   -1.269
 
loading

Abbvie Inc Aktie (ABBV) Neueste Nachrichten

pulisher
09:15 AM

AbbVie Announces Positive Topline Results from Phase 3 Pivotal Studies Evaluating Upadacitinib in Adults and Adolescents with Vitiligo - Investing News Network

09:15 AM
pulisher
08:56 AM

AbbVie (ABBV) Reports Promising Results from Phase 3 Studies on RINVOQ for Vitiligo - GuruFocus

08:56 AM
pulisher
05:33 AM

Will AbbVie Inc. (Common Stock) (4AB0) stock test record highs in 2025Portfolio Update Report & Breakout Confirmation Trade Signals - newser.com

05:33 AM
pulisher
Oct 28, 2025

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) – Clinical Overview, Companies, Therapeutic Assessment, Treatment Approaches, Pipeline Insights | AbbVie, Sanofi - Barchart.com

Oct 28, 2025
pulisher
Oct 28, 2025

AbbVie: Deep Discount Before Earnings (NYSE:ABBV) - Seeking Alpha

Oct 28, 2025
pulisher
Oct 28, 2025

Should You Buy AbbVie Stock Ahead of Q3 Earnings Report? - sharewise.com

Oct 28, 2025
pulisher
Oct 28, 2025

Allergan Aesthetics and Girls Inc., in Partnership with SkinSpirit, Inspire Future Women Leaders in STEM - PR Newswire

Oct 28, 2025
pulisher
Oct 28, 2025

Want Decades of Passive Income? Buy This Index Fund and Hold It Forever. - The Motley Fool

Oct 28, 2025
pulisher
Oct 28, 2025

Will AbbVie Inc. stock attract more institutional investorsEarnings Overview Summary & Capital Protection Trade Alerts - newser.com

Oct 28, 2025
pulisher
Oct 27, 2025

Can AbbVie Inc. stock attract analyst upgrades2025 Year in Review & Risk Controlled Swing Trade Alerts - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Chronic Idiopathic Constipation Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment DelveInsight | ABBVIE, Eisai Co, Anji Pharma, Yuhan, Renexxion Ireland, Forest - Barchart.com

Oct 27, 2025
pulisher
Oct 27, 2025

AbbVie Defends Challenge Of Colorado's Discount Drug Law - Law360

Oct 27, 2025
pulisher
Oct 27, 2025

Can AbbVie Inc. stock withstand economic slowdownEarnings Overview Summary & Fast Exit and Entry Trade Guides - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Will AbbVie Inc. (Common Stock) (4AB0) stock extend growth storyPortfolio Gains Report & Free Weekly Chart Analysis and Trade Guides - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Can AbbVie Inc. stock surprise markets with earningsPortfolio Growth Summary & Real-Time Chart Pattern Alerts - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

What's in Store for These 5 Pharma Bigwigs This Earnings Season? - TradingView

Oct 27, 2025
pulisher
Oct 27, 2025

Pigmentation Disorders Treatment Market Is Booming Worldwide 2025-2032 |Abbvie Inc., Edesa Biotech, Inc., Amgen - openPR.com

Oct 27, 2025
pulisher
Oct 27, 2025

Is AbbVie Inc. stock a buy on dips2025 Geopolitical Influence & Long Hold Capital Preservation Plans - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Is AbbVie Inc. stock resilient to inflationJuly 2025 Catalysts & Risk Controlled Stock Pick Alerts - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Ophthalmic Drugs Market Set for Dynamic Growth with Key Players Abbvie Inc. (Allergan Plc), Alcon, Inc., Novartis AG - openPR.com

Oct 27, 2025
pulisher
Oct 27, 2025

Fish Skin Disease Market to Witness Remarkable Growth With GSK - openPR.com

Oct 27, 2025
pulisher
Oct 27, 2025

How AbbVie Inc. stock performs in rising dollar environmentWeekly Earnings Recap & Daily Oversold Bounce Ideas - newser.com

Oct 27, 2025
pulisher
Oct 26, 2025

How sentiment analysis helps forecast AbbVie Inc.July 2025 Movers & Comprehensive Market Scan Insights - newser.com

Oct 26, 2025
pulisher
Oct 26, 2025

Why AbbVie Inc. (4AB) stock stays on top picksPortfolio Risk Summary & Technical Pattern Alert System - newser.com

Oct 26, 2025
pulisher
Oct 25, 2025

How the Story for AbbVie Is Evolving After Key Pipeline Wins and Analyst Shifts - Yahoo Finance

Oct 25, 2025
pulisher
Oct 25, 2025

AbbVie Stock Forecast: Where Analysts See the Stock Going by 2027 - TIKR.com

Oct 25, 2025
pulisher
Oct 24, 2025

AbbVie’s ABBV-932 Study: A New Hope for Bipolar Disorder Treatment? - TipRanks

Oct 24, 2025
pulisher
Oct 24, 2025

Wall Street Analysts Think AbbVie (ABBV) Is a Good Investment: Is It? - sharewise.com

Oct 24, 2025
pulisher
Oct 24, 2025

Analysts Estimate AbbVie (ABBV) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance

Oct 24, 2025
pulisher
Oct 23, 2025

AbbVie Draws Growing Institutional Confidence As Investors Seek Steady Growth - sharewise.com

Oct 23, 2025
pulisher
Oct 23, 2025

AbbVie (ABBV) Stock Up 28% YTD as New Drug Wins and Analyst Upgrades Fuel Optimism - ts2.tech

Oct 23, 2025
pulisher
Oct 23, 2025

Wolfe Research Adjusts AbbVie Price Target to $275 From $235, Maintains Outperform Rating - MarketScreener

Oct 23, 2025
pulisher
Oct 23, 2025

United States Breast Reconstruction Market Growth Trends and Forecast Report 2025-2033, Profiles of Mentor Worldwide, AbbVie, Integra, Sientra, Stryker, Establishment Labs, RTI Surgical, TELA Bio - Yahoo Finance

Oct 23, 2025
pulisher
Oct 23, 2025

How AbbVie Inc. (Common Stock) (4AB0) stock behaves under inflation pressureEarnings Summary Report & Free Weekly Chart Analysis and Trade Guides - newser.com

Oct 23, 2025
pulisher
Oct 22, 2025

AbbVie (ABBV) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance

Oct 22, 2025
drug_manufacturers_general JNJ
$185.84
price down icon 0.59%
drug_manufacturers_general NVS
$123.01
price down icon 0.30%
drug_manufacturers_general MRK
$86.93
price down icon 0.02%
drug_manufacturers_general NVO
$52.01
price up icon 0.00%
$292.85
price up icon 0.26%
Kapitalisierung:     |  Volumen (24h):